2.4613
+0.0413
+(1.71%)
As of 11:19:24 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-13,498.0000
-7,205.0000
-5,477.0000
-6,826.8630
-5,370.1920
Investing Cash Flow
9,175.0000
-6,023.0000
--
--
4,564.8130
Financing Cash Flow
411.0000
20,472.0000
2,250.0000
2,050.0000
6,292.6330
End Cash Position
2,782.0000
8,556.0000
1,312.0000
4,539.2290
9,316.0920
Issuance of Capital Stock
232.0000
22,425.0000
--
--
6,267.6330
Issuance of Debt
-13.0000
230.0000
2,250.0000
2,000.0000
--
Free Cash Flow
-13,498.0000
-7,205.0000
-5,477.0000
-6,826.8630
-5,370.1920
12/31/2020 - 6/30/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PRTG Portage Biotech Inc.
4.3631
+2.39%
EPRX Eupraxia Pharmaceuticals Inc.
3.0247
+3.23%
VBIZF Viva Biotech Holdings
0.0950
-43.52%
UPB Upstream Bio, Inc.
9.84
-5.29%
SEER Seer, Inc.
2.3800
-0.42%
CELU Celularity Inc.
2.5900
+3.60%
ALA.AX Arovella Therapeutics Limited
0.2000
+2.56%
ESLA Estrella Immunopharma, Inc.
1.0909
-3.46%
PRLD Prelude Therapeutics Incorporated
1.1800
-2.88%
ITOS iTeos Therapeutics, Inc.
7.72
+1.05%